Carl-Henrik Heldin

22PUBLICATIONS
58CO-AUTHORS
Molecular targetsHaematological tumoursCancer cell biologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 12, 2026
SNAI1 ablation alters integrin-mediated adhesion and endocytic fate.

|Jul 04, 2026
SHP2 negatively regulates TGF-β signaling by destabilizing the TGF-β type I receptor.

|Feb 04, 2026
TGFβ signaling promotes cell cycle progression and resistance to the CDK4/6 inhibitor palbociclib through SOX4 transcriptional modulation in breast cancer cells.

Mohamad Moustafa Ali, Yuka Itoh, Aisha Mariama Pereira Badji

|Mar 28, 2025
The transcription factor LHX2 mediates and enhances oncogenic BMP signaling in medulloblastoma.

Yae Ohata, Mohamad M Ali, Yutaro Tsubakihara

|May 13, 2023
The E3 Ubiquitin Ligase TRIM21 Regulates Basal Levels of PDGFRβ.

Niki Sarri, Natalia Papadopoulos, Johan Lennartsson

|Feb 25, 2023
Hyaluronan-Induced CD44-iASPP Interaction Affects Fibroblast Migration and Survival.

Chun-Yu Lin, Kaustuv Basu, Aino Ruusala

Pageof 4

Frequent Collaborators

8 joint publications

Aristidis Moustakas

5 joint publications

Mohamad Moustafa Ali

4 joint publications

Kohei Miyazono

4 joint publications

Paraskevi Heldin